Greece Announces 1,381 Coronavirus Cases; Declining Hospitalizations

Greek health authority EODY announced on Monday that a total of 1,381 new cases of coronavirus have been diagnosed in the country over the last 24 hours. Only three cases were detected at the country’s gateways.

Yesterday, Sunday, there were a total of 877 coronavirus cases diagnosed.

There were 50 deaths in this who had succumbed with the virus. A total of 11,822 deaths have been recorded since the beginning of the pandemic. Nearly all, or 95.2%, of the victims, suffered from an underlying disease and / or were age 70 years or older.

Health authorities in Greece carried out approximately 22,000 in the last 24 hours.

The announcement stated that the total number of coronavirus cases diagnosed since the beginning of the pandemic is now 391,181, showing daily increase of + 0.4%, of which 51.2% are male.

Based on the confirmed cases over the past week, 31 are considered to be related to travel from abroad and 2,077 are related to an already-known case.

The number of this undergoing the invasive process of intubation came to 563; 61.3% of these individuals are male. Their median age is 67 years. More than three quarters of them, or 83.7%, have underlying disease and / or are age 70 years and older. A total of 2,353 patients have been discharged from ICUs across Greece since the beginning of the pandemic.

The number of daily hospital admissions of new Covid-19 patients in Greece is now 210, showing a welcome daily change  of -8.3%. The average number of admissions over the last seven days is 271. The median age of all these individuals is 44 years while the median age of death is 78 years.

 Attica has 654 new cases; Thessaloniki 101

There were 654 new new cases of coronavirus in Attica, while 101 new infections were detected in Thessaloniki.

The geographical distribution of the majority of the 1,381 new Covid-19 cases announced today by EODY is as follows:

82 cases in Eastern Attica
77 cases in Northern Sector of Athens
25 cases in West Attica
126 cases in Western Sector of Athens
160 cases in Central Sector of Athens
79 cases in Southern Sector of Athens
101 cases in Piraeus

101 cases in P.E. Thessaloniki

42 cases in P.E. Etoloakarnania

50 cases in P.E. Of Achaia

25 cases in P.E. Of Evia

32 cases in P.E. Heraklion

40 cases in P.E. Ioannina

38 cases in P.E. Of Larissa

43 cases in P.E. Magnesia

The EODY also announced that a total of 38 cases are still under investigation.

This past weekend, the world received encouraging news as a study in the UK assured that the Indian variant of the virus was indeed suppressed by vaccines that are currently on the market.

Current coronavirus vaccines are effective against Indian variant

The Indian coronavirus variant can be suppressed by vaccines that are already in use, according to a study published on Saturday in England.

The UK Government Public Health Service announced on Saturday that vaccines that are already being used are almost as effective in protecting against the Indian variant of the coronavirus as they are for other strains.

The study, which was completed by public health authorities in England, found that both the Pfizer/BioNTech and the AstraZeneca vaccines offer a good amount of protection against the Indian variant.

The study, which was conducted between April 5 and May 16, found that the Pfizer/BioNTech vaccine was 88 percent effective at preventing symptomatic disease from the Indian variant once an individual was fully vaccinated. “Fully vaccinated” in this context means that a person has received two doses of the vaccine, and two full weeks have passed since their last shot.

This result is very encouraging, as the Pfizer vaccine has been found to be 93 percent effective against other variants.

During the same study period, the AstraZeneca vaccine was found to be 60 percent effective against the new strain of the coronavirus, compared with 66 percent against the British variant first detected in Kent.

Additionally, there is a certain level of immunity which can be reached simply through getting one dose of the vaccine. The two vaccines studied seem to be 33 percent effective against symptomatic disease caused by the Indian variant three weeks after only the first dose, compared with about 50 percent against the British variant.